Upcoming Dividend • May 20
Upcoming dividend of €0.089 per share Eligible shareholders must have bought the stock before 26 May 2026. Payment date: 28 May 2026. Payout ratio is a comfortable 49% and this is well supported by cash flows. Trailing yield: 4.3%. Lower than top quartile of British dividend payers (5.7%). In line with average of industry peers (4.3%). Tillkännagivande • Mar 12
Mapfre, S.A. to Report Nine Months, 2026 Results on Oct 28, 2026 Mapfre, S.A. announced that they will report nine months, 2026 results on Oct 28, 2026 Tillkännagivande • Feb 13
Mapfre, S.A., Annual General Meeting, Mar 13, 2026 Mapfre, S.A., Annual General Meeting, Mar 13, 2026. Location: palacio municipal de congresos, campo de las naciones, avenida de la capital de espana sn, madrid Spain Tillkännagivande • Feb 13
Mapfre, S.A., Annual General Meeting, Mar 14, 2025 Mapfre, S.A., Annual General Meeting, Mar 14, 2025. Location: palacio municipal de congresos, campo de las naciones, avenida de la capital de espana sn, madrid Spain Tillkännagivande • Feb 12
Mapfre, S.A. to Report Q1, 2025 Results on Apr 25, 2025 Mapfre, S.A. announced that they will report Q1, 2025 results on Apr 25, 2025 Tillkännagivande • May 24
Mapfre, S.A. to Report Q3, 2024 Results on Oct 29, 2024 Mapfre, S.A. announced that they will report Q3, 2024 results on Oct 29, 2024 Declared Dividend • Feb 27
Final dividend of €0.073 announced Shareholders will receive a dividend of €0.073. Ex-date: 28th November 2024 Payment date: 1st January 1970 Dividend yield will be 3.6%, which is lower than the industry average of 5.0%. Sustainability & Growth Dividend is covered by both earnings (68% earnings payout ratio) and cash flows (33% cash payout ratio). The dividend has increased by an average of 1.5% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 32% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Tillkännagivande • Feb 15
Mapfre, S.A., Annual General Meeting, Mar 15, 2024 Mapfre, S.A., Annual General Meeting, Mar 15, 2024, at 11:30 Central European Standard Time. Location: The Palacio Municipal de Congresos del Campo de las Naciones, (Avenida de la Capital de España), Madrid Spain Agenda: To consider Annual Financial Statements, distribution of the result, and corporate management; to consider Appointment, re-election and ratification, where appropriate, of board directors; to consider Re-election and Appointment of Auditors; to consider Remuneration of board directors; to consider Authorization and delegation of powers for the interpretation, correction, supplementation, execution, and development of the resolutions adopted by the Annual General Meeting; and to consider Delegation of powers to execute and record as a public deed the resolutions passed at the Annual General Meeting. Tillkännagivande • Jan 16
Mapfre, S.A. to Report Fiscal Year 2023 Results on Feb 14, 2024 Mapfre, S.A. announced that they will report fiscal year 2023 results on Feb 14, 2024 Upcoming Dividend • Nov 21
Upcoming dividend of €0.049 per share at 7.1% yield Eligible shareholders must have bought the stock before 28 November 2023. Payment date: 30 November 2023. Payout ratio is a comfortable 68% and the cash payout ratio is 77%. Trailing yield: 7.1%. Within top quartile of British dividend payers (6.2%). Higher than average of industry peers (4.8%). Tillkännagivande • Jul 28
Mapfre, S.A. (BME:MAP) entered into an agreement to acquire 94% stake in Insignia Life S.A. de C.V. for MXN 1.6 billion. Mapfre, S.A. (BME:MAP) entered into an agreement to acquire 94% stake in Insignia Life S.A. de C.V. for MXN 1.6 billion on July 27, 2023. An additional variable price has also been agreed, which be paid in line with the achievement of objectives. As part of the agreement, Insignia Life will continue operating as an independent brand. The company’s current management team, led by its president, Isaac Zetune, and general manager, Antonio Fernández, will continue to run the company in this new stage. These executives will also continue to hold 6% of the shares of Insignia Life. Completion of the transaction is subject to authorization by the corresponding regulators of the Mexican market. Tillkännagivande • Jun 29
Mapfre, S.A. to Report Q2, 2023 Results on Jul 28, 2023 Mapfre, S.A. announced that they will report Q2, 2023 results on Jul 28, 2023 Upcoming Dividend • May 15
Upcoming dividend of €0.069 per share at 7.8% yield Eligible shareholders must have bought the stock before 22 May 2023. Payment date: 24 May 2023. Payout ratio is a comfortable 69% but the company is paying out more than the cash it is generating. Trailing yield: 7.8%. Within top quartile of British dividend payers (5.9%). Higher than average of industry peers (4.4%). Reported Earnings • Feb 11
Full year 2022 earnings released: EPS: €0.21 (vs €0.25 in FY 2021) Full year 2022 results: EPS: €0.21 (down from €0.25 in FY 2021). Revenue: €24.1b (up 21% from FY 2021). Net income: €642.1m (down 16% from FY 2021). Profit margin: 2.7% (down from 3.9% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.1% p.a. on average during the next 3 years, compared to a 24% growth forecast for the Insurance industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings. Tillkännagivande • Dec 16
Mapfre, S.A. to Report Fiscal Year 2022 Results on Feb 09, 2023 Mapfre, S.A. announced that they will report fiscal year 2022 results on Feb 09, 2023 Upcoming Dividend • Nov 21
Upcoming dividend of €0.049 per share Eligible shareholders must have bought the stock before 28 November 2022. Payment date: 30 November 2022. Payout ratio is a comfortable 60% but the company is paying out more than the cash it is generating. Trailing yield: 7.9%. Within top quartile of British dividend payers (5.7%). Higher than average of industry peers (4.6%). Reported Earnings • Oct 30
Third quarter 2022 earnings released: EPS: €0.049 (vs €0.05 in 3Q 2021) Third quarter 2022 results: EPS: €0.049 (down from €0.05 in 3Q 2021). Revenue: €5.56b (up 18% from 3Q 2021). Net income: €150.8m (down 6.0% from 3Q 2021). Profit margin: 2.7% (down from 3.4% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 4.5% p.a. on average during the next 3 years, compared to a 28% growth forecast for the Insurance industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings. Reported Earnings • Jul 29
Second quarter 2022 earnings released: EPS: €0.06 (vs €0.06 in 2Q 2021) Second quarter 2022 results: EPS: €0.06 (vs €0.06 in 2Q 2021). Revenue: €5.06b (flat on 2Q 2021). Net income: €183.1m (down 4.0% from 2Q 2021). Profit margin: 3.6% (down from 3.7% in 2Q 2021). Over the next year, revenue is forecast to grow 21%, compared to a 151% growth forecast for the industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has fallen by 14% per year, which means it is significantly lagging earnings. Upcoming Dividend • May 20
Upcoming dividend of €0.069 per share Eligible shareholders must have bought the stock before 27 May 2022. Payment date: 31 May 2022. Payout ratio is a comfortable 58% but the company is not cash flow positive. Trailing yield: 8.2%. Within top quartile of British dividend payers (4.9%). Higher than average of industry peers (5.1%). Reported Earnings • Feb 12
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Full year 2021 results: EPS: €0.25 (up from €0.17 in FY 2020). Revenue: €19.8b (up 7.0% from FY 2020). Net income: €765.2m (up 45% from FY 2020). Profit margin: 3.9% (up from 2.8% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 22%, compared to a 530% growth forecast for the insurance industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings. Upcoming Dividend • Nov 19
Upcoming dividend of €0.049 per share Eligible shareholders must have bought the stock before 26 November 2021. Payment date: 30 November 2021. Trailing yield: 7.1%. Within top quartile of British dividend payers (4.0%). Higher than average of industry peers (3.8%). Reported Earnings • Oct 30
Third quarter 2021 earnings released: EPS €0.053 (vs €0.06 in 3Q 2020) The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: €5.39b (up 23% from 3Q 2020). Net income: €160.4m (down 11% from 3Q 2020). Profit margin: 3.0% (down from 4.1% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has fallen by 12% per year, which means it is performing significantly worse than earnings. Reported Earnings • Oct 30
Third quarter 2021 earnings released: EPS €0.053 (vs €0.06 in 3Q 2020) The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: €5.39b (up 23% from 3Q 2020). Net income: €160.4m (down 11% from 3Q 2020). Profit margin: 3.0% (down from 4.1% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has fallen by 12% per year, which means it is performing significantly worse than earnings. Upcoming Dividend • May 13
Upcoming dividend of €0.061 per share Eligible shareholders must have bought the stock before 20 May 2021. Payment date: 24 May 2021. Trailing yield: 6.6%. Within top quartile of British dividend payers (4.1%). Higher than average of industry peers (3.6%). Reported Earnings • May 03
First quarter 2021 earnings released: EPS €0.06 (vs €0.04 in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: €4.53b (up 1.8% from 1Q 2020). Net income: €173.3m (up 37% from 1Q 2020). Profit margin: 3.8% (up from 2.8% in 1Q 2020). Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has fallen by 15% per year, which means it is performing significantly worse than earnings. Reported Earnings • Feb 12
Full year 2020 earnings released: EPS €0.17 (vs €0.20 in FY 2019) The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: €21.4b (down 3.1% from FY 2019). Net income: €526.5m (down 14% from FY 2019). Profit margin: 2.5% (down from 2.8% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has fallen by 16% per year, which means it is performing significantly worse than earnings. Is New 90 Day High Low • Dec 17
New 90-day high: €1.76 The company is up 21% from its price of €1.45 on 18 September 2020. The British market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Insurance industry, which is up 15% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €3.04 per share. Upcoming Dividend • Dec 11
Upcoming Dividend of €0.041 Per Share Will be paid on the 22nd of December to those who are registered shareholders by the 18th of December. The trailing yield of 8.6% is in the top quartile of British dividend payers (4.9%), and it is higher than industry peers (4.0%). Is New 90 Day High Low • Dec 02
New 90-day high: €1.70 The company is up 10.0% from its price of €1.55 on 03 September 2020. The British market is up 8.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Insurance industry, which is up 13% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €2.51 per share. 
